'Notice Of Removal By Tevaq Women's Health, Inc. Individually, And As A Successor In Interst To Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Teva Pharmaceuticals Usa, Inc., Teva Women's Health Llc F/k/a Teva Women's Health, Inc., Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc. , Filed By Tevaq Women's Health, Inc. Individually, And As A Successor In Interst To Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Teva Pharmaceuticals Usa, Inc., Teva Women's Health Llc F/k/A Teva Women's Health, Inc., Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc.. (attachments: # 1 Designation Form, # 2 Designation Form, # 3 Designation Form)(rubenstein, Brian)'
'Answer To Complaint By Teva Pharmaceuticals Usa, Inc..(rubenstein, Brian)'
'Answer To Complaint By Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'
'Answer To Complaint By Tevaq Women's Health, Inc. Individually, And As A Successor In Interst To Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'
Case number 2:20-cv-01620 was filed in the U.S. District Court for the Eastern District of Pennsylvania on March 25.